Ghent University Academic Bibliography

Advanced

Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator

E Dhondt, W Hutse, X Vanmeerhaeghe and Luc Jordaens UGent (1995) EUROPEAN HEART JOURNAL. 16(5). p.716-718
abstract
Superior vena cava syndrome is a rare, but nevertheless well known complication of permanent pacemaker implantation. Nowadays cardioverter defibrillators are also routinely implanted transvenously. A superior vena cava syndrome occurred in a 48-year-old female 2 years after implantation of cardioverter defibrillator. The clinical problem, in the presence of a predisposing thrombophilic condition (circulating lupus anticoagulant), resolved only partially after treatment with thrombolytics and oral anticoagulation. This syndrome should be recognized as a possible important complication of defibrillator therapy and requires lifelong anticoagulation.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (letterNote)
publication status
published
subject
keyword
SUPERIOR VENA CAVA SYNDROME, THROMBOSIS, SUDDEN DEATH, IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
journal title
EUROPEAN HEART JOURNAL
Eur. Heart J.
volume
16
issue
5
pages
716 - 718
Web of Science type
Note
ISSN
0195-668X
language
English
UGent publication?
yes
classification
A1
id
194149
handle
http://hdl.handle.net/1854/LU-194149
date created
2004-01-14 13:42:00
date last changed
2016-12-19 15:38:11
@article{194149,
  abstract     = {Superior vena cava syndrome is a rare, but nevertheless well known complication of permanent pacemaker implantation. Nowadays cardioverter defibrillators are also routinely implanted transvenously. 
A superior vena cava syndrome occurred in a 48-year-old female 2 years after implantation of cardioverter defibrillator. The clinical problem, in the presence of a predisposing thrombophilic condition (circulating lupus anticoagulant), resolved only partially after treatment with thrombolytics and oral anticoagulation. This syndrome should be recognized as a possible important complication of defibrillator therapy and requires lifelong anticoagulation.},
  author       = {Dhondt, E and Hutse, W and Vanmeerhaeghe, X and Jordaens, Luc},
  issn         = {0195-668X},
  journal      = {EUROPEAN HEART JOURNAL},
  keyword      = {SUPERIOR VENA CAVA SYNDROME,THROMBOSIS,SUDDEN DEATH,IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)},
  language     = {eng},
  number       = {5},
  pages        = {716--718},
  title        = {Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator},
  volume       = {16},
  year         = {1995},
}

Chicago
Dhondt, E, W Hutse, X Vanmeerhaeghe, and Luc Jordaens. 1995. “Superior Vena Cava Syndrome After Implantation of a Transvenous Cardioverter-defibrillator.” European Heart Journal 16 (5): 716–718.
APA
Dhondt, E, Hutse, W., Vanmeerhaeghe, X., & Jordaens, L. (1995). Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator. EUROPEAN HEART JOURNAL, 16(5), 716–718.
Vancouver
1.
Dhondt E, Hutse W, Vanmeerhaeghe X, Jordaens L. Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator. EUROPEAN HEART JOURNAL. 1995;16(5):716–8.
MLA
Dhondt, E, W Hutse, X Vanmeerhaeghe, et al. “Superior Vena Cava Syndrome After Implantation of a Transvenous Cardioverter-defibrillator.” EUROPEAN HEART JOURNAL 16.5 (1995): 716–718. Print.